Robert Nelsen

Insider Reports History

Entity
Individual
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Signature
/s/ Matthew Lang, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Nelsen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 9.67M $178M $18.42 Jun 2, 2021 Held by ARCH Venture Fund VIII, L.P.
Sana Biotechnology, Inc. Director, 10%+ Owner Common Stock 12.4M $68.5M $5.50 Feb 8, 2024 Indirect
Lyell Immunopharma, Inc. Director, 10%+ Owner Common Stock 18.2M $41.5M $2.28 Jun 14, 2024 ARCH Venture Fund IX,L.P.
Lyell Immunopharma, Inc. Director, 10%+ Owner Common Stock 18.2M $41.5M $2.28 Jun 14, 2024 ARCH Venture Fund IX Overage, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 6.13M $38.3M $6.25 Feb 15, 2024 By ARCH Venture Fund X, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 6.13M $38.3M $6.25 Feb 15, 2024 By ARCH Venture Fund X Overage, L.P.
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 3.2M $20M $6.25 Feb 15, 2024 By ARCH Venture Fund XII, L.P.
Vir Biotechnology, Inc. Director Common Stock 584K $5.52M $9.46 May 30, 2024 Direct
Vir Biotechnology, Inc. Director Common Stock 33.9K $321K $9.46 May 30, 2024 Indirect
Denali Therapeutics Inc. Director Common Stock 12.4K $229K $18.42 Jun 2, 2021 Direct
Prime Medicine, Inc. Director, 10%+ Owner Common Stock 16.1K $101K $6.25 Feb 15, 2024 Indirect
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16K $24.5K $1.53 May 30, 2024 Direct
Sana Biotechnology, Inc. Director, 10%+ Owner Common Stock 1.35K $7.44K $5.50 Feb 8, 2024 Direct
Lyell Immunopharma, Inc. Director, 10%+ Owner Option (right to buy) 130K Jun 14, 2024 Direct
Sana Biotechnology, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 65K Jun 6, 2024 Direct
Prime Medicine, Inc. Director, 10%+ Owner Stock Option (right to buy) 45K Jun 12, 2024 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 6.22K Jun 2, 2021 Direct
Denali Therapeutics Inc. Director Restricted Stock Units 0 Jun 1, 2021 Direct

Insider Reports Filed by Robert Nelsen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Jun 14, 2024 1 $0 4 Jun 17, 2024 Director, 10%+ Owner
PRME Prime Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4/A Jul 15, 2024 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jun 6, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. May 30, 2024 2 $0 4 Jun 3, 2024 Director
PRME Prime Medicine, Inc. Feb 15, 2024 1 $20M 4 Feb 20, 2024 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Feb 8, 2024 3 $10M 4 Feb 12, 2024 Director, 10%+ Owner
LYEL Lyell Immunopharma, Inc. Sep 8, 2023 1 $0 4 Sep 8, 2023 Director, 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 16, 2023 1 $0 4 Jun 20, 2023 Director, 10%+ Owner
PRME Prime Medicine, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. May 22, 2023 2 $0 4 May 24, 2023 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jan 5, 2023 1 $0 4 Jan 6, 2023 Director, 10%+ Owner
PRME Prime Medicine, Inc. Oct 24, 2022 10 $13.6M 4 Oct 26, 2022 Director, 10%+ Owner
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3/A Oct 24, 2022 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Oct 5, 2022 1 $0 4 Oct 6, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Sep 2, 2022 8 $0 4 Sep 7, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Aug 30, 2022 8 $0 4 Sep 1, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Aug 24, 2022 8 $0 4 Aug 26, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Aug 18, 2022 4 $0 4 Aug 22, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Aug 12, 2022 12 $0 4 Aug 16, 2022 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jul 5, 2022 1 $0 4 Jul 7, 2022 Director
VIR Vir Biotechnology, Inc. Jun 8, 2022 4 $0 4 Jun 10, 2022 Director, 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Jun 6, 2022 1 $0 4 Jun 8, 2022 Director
VIR Vir Biotechnology, Inc. Jun 2, 2022 3 $0 4 Jun 6, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. May 23, 2022 2 $0 4 May 25, 2022 Director, 10%+ Owner
SANA Sana Biotechnology, Inc. Apr 5, 2022 1 $0 4 Apr 6, 2022 Director
VIR Vir Biotechnology, Inc. Dec 20, 2021 1 $0 4/A May 10, 2022 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Nov 29, 2021 3 $0 4 Dec 1, 2021 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Nov 22, 2021 3 $0 4 Nov 24, 2021 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Jul 1, 2021 3 $0 4 Jul 6, 2021 Director, 10%+ Owner
VIR Vir Biotechnology, Inc. Jun 22, 2021 3 $0 4 Jun 24, 2021 Director, 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 21, 2021 6 $0 4 Jun 23, 2021 Director, 10%+ Owner
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director, 10%+ Owner
DNLI Denali Therapeutics Inc. Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
VIR Vir Biotechnology, Inc. May 21, 2021 2 $0 4 May 25, 2021 Director, 10%+ Owner
DNLI Denali Therapeutics Inc. Mar 22, 2021 6 $0 4 Jun 3, 2021 Director